All
Pfizer Issues Voluntary Nationwide Recall of Lots of Accupril
Pfizer has issued a voluntary nationwide recall of lots of Accupril due to N-nitroso-quinapril content.
EMA Recommends EU Conditional Approval of Roche’s Mosunetuzumab
EMA is recommending EU conditional approval of Roche’s potential first-in-class bispecific antibody mosunetuzumab for people with relapsed or refractory follicular lymphoma.
Novo Nordisk Announces Positive Scientific Opinion from EMA on Human Insulin
EMA has granted Novo Nordisk a positive scientific opinion on human insulin with more flexible storage without refrigeration.
FDA Requesting Comment on Pharmaceutical Quality/Chemistry Manufacturing and Controls Data Exchange
FDA is requesting comment on draft document “Pharmaceutical Quality/Chemistry Manufacturing and Controls Data Exchange.”
FDA Approves Kite’s CAR T-Cell Therapy Manufacturing Facility in Maryland
FDA has approved commercial production at Kite’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland.
Catalent to Invest $350 Million in Manufacturing Facility in Bloomington, Indiana
Catalent will invest $350 million into integrated biologics drug substance and drug product manufacturing at Bloomington, Indiana facility.
EIB Provides €15 million to IRBM
The European Investment Bank has provided €15 million to fund coronavirus research at IRBM.
Otsuka Pharmaceutical and Osaka University Enter Exclusive License Agreement
Otsuka Pharmaceutical and Osaka University have entered an exclusive license agreement on a new anti-tumor antibody.
Takeda’s TAKHZYRO Prefilled Syringe Now Available for Patients with Hereditary Angioedema
Takeda’s TAKHZYRO prefilled syringe is now available for patients with hereditary angioedema aged 12 years and older in the United States.
Clinical Trial Diversity Advances in Regulatory Agenda
New guidance from FDA and legislation from Congress promote clinical trial diversity.
AmoyDX and AstraZeneca Enter Master Collaboration Agreement
AmoyDX has entered a Master Collaboration Agreement with AstraZeneca for multiple companion diagnostics programs in China, EU, and Japan.
Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein
Thermo Fisher Scientific has launched its first GMP-manufactured Cas9 protein for clinical genome editing research.
High Purity New England Launches Third Facility
High Purity New England has launched its third facility, focused on single-use assemblies.
GSK to Acquire Sierra Oncology for $1.9 Billion
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9 billion.
Mylan Pharmaceuticals Issues Voluntary Recall of Insulin Glargine Injection
Mylan Pharmaceuticals is issuing a voluntary recall of one batch of insulin glargine injection due to the potential for a missing label in the batch.
ReiThera and Exothera Collaborate on Manufacturing Vaccines for Low and Middle-income Countries
ReiThera and Exothera are collaborating to develop a large-scale, low-cost-per-dose manufacturing process to deliver novel vaccines to low and middle-income countries.
Achilles Therapeutics Announces Manufacturing Expansion in the UK and US
Achilles Therapeutics has announced that it will expand its clinical manufacturing capabilities in the UK and enter a partnership agreement for expansion in the US.
Swissmedic Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine
Swissmedic grants conditional marketing authorization for Novavax COVID-19 vaccine for individuals aged 18 years or older in Switzerland.
Tjoapack Announces Completion of Netherlands Packaging Facility
Tjoapack has doubled its packaging capacity with the completion of its Netherlands facility expansion.
VectorBuilder to Expand with $500 Million Gene Delivery Research and Manufacturing Campus
VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.
FDA Revives Initiative to Identify and Reward Quality Drug Operations
FDA is reviving efforts to establish a Quality Management Maturity program.
University Hospital Hamburg-Eppendorf Leads Trial to Explore Personalized Medicine in COVID-19
Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for treatment of COVID-19.
Opus Enters Collaboration with Resilience for AAV-Based Gene Therapy Development and Manufacturing
Opus enters a strategic collaboration with Resilience for AAV-based gene therapy development and manufacturing for inherited retinal diseases.
Orchard Therapeutics Announces Reimbursement Agreement for Libmeldy
Orchard Therapeutics announces reimbursement agreement, which will make Libmeldy available for all eligible MLD patients in Italy.
EC Approves Dupixent for Treatment of Severe Asthma in Young Children
Dupixent has been approved by the EC for children aged 6 to 11 years with severe asthma with type 2 inflammation.
Ymmunobio AG Signs Patent Purchase Agreement with LeukoCom GmbH
Ymmunobio AG has signed a patent purchase agreement with LeukoCom GmbH to expand its development of cancer therapies.
Legislation Targets High Cost of Clinical Trials
Democrats have proposed a measure to facilitate access to less costly comparator drugs needed in clinical trials, while another bill aims to increase transparency in the costs of clinical trials.
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Pfizer plans to acquire ReViral and its respiratory syncytial virus therapeutic candidates to strengthen Pfizer’s capabilities in infectious disease research.
Lonza and Asher Biotherapeutics to Collaborate on Manufacturing AB359
Lonza and Asher Biotherapeutics have entered a manufacturing agreement for a cis-targeted IL-2 fusion protein, AB359.
IAVI and Moderna Partner to Tackle Global Health Priorities Using mRNA for Vaccines and Antibodies
IAVI and Moderna have announced a new collaboration to employ mRNA technology to meet the challenge of a range of global health issues.